Danish biotech company Bavarian Nordic is set to release its third-quarter report on Friday.
Bavarian Nordic is expected to report an EBITDA margin of 34.6 percent, according to the company’s consensus based on estimates from six analysts.
Bavarian NordicReport date2026-11-13(million Danish kroner)Q3-2026, forecastNumber of estimatesSales1 6896EBITDA margin, percent34.66Source: Company
Share price performance around the latest reports as follows:
PeriodReport dateShare price performance on report day, %Q2-20262026-08-219.1Q1-20262026-05-13-5.1Q4-20252026-03-12-3.0Q3-20252025-11-14-5.7Q2-20252025-08-220.1Q1-20252025-05-096.2Q4-20242025-03-052.7Q3-20242024-11-15-17.4
